Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lybrido food effect pharmacokinetic crossover study
NL-OMON41076Active, not recruiting
- Sponsor
- FSD Pharma
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sildenafil + testosterone, sildenafil and testosterone in female sexual dysfunction (FSD) (2 arms), sponsored by FSD Pharma. Primary endpoints: AUCinf 90% confidence interval ratio, Cmax 90% confidence interval ratio and 1 more. Started Jun 2014; status: active, not recruiting.
02
Drugs
sildenafil + testosteronesildenafiltestosterone
03
Conditions
female sexual dysfunction (FSD)
Beyond the preview
Go deeper on NL-OMON41076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41076.